Friday, July 10, 2026

Drug profile · INN

sufentanil

sufentanil (DZUVEO) is a mu opioid receptor agonist.

EMA: approved NMPA: clinical trials Nervous system (N01) N01AH03
Patents linked 0
Pipeline programs 9
News articles 0
Drug details — sufentanil
Class
Nervous system (N01)
Route
Patents
0
Programs
9
Data quality
0.83

Quick answer

sufentanil (DZUVEO) is a mu opioid receptor agonist.

Key facts

INN sufentanil
Brand DZUVEO
Mechanism Mu opioid receptor agonist
Therapeutic class Nervous system (N01)
ATC code N01AH03

Mechanism of action

Mu opioid receptor agonist

Approval history

Authority Status Date
EMA approved
NMPA clinical trials

Pipeline programs

  1. APHP211035 Phase 3 · PARItec · vaso-occlusive crisis due to sickle cell disease
  2. Sufentanil 30 MCG Sublingual Tablet Phase 3 · United Therapeutics Europe · Traumatic Injury
  3. Fentanyl hameln 50 microgram/ml for healthy volunteers, opioid use… Approved · Disc Medicine · healthy volunteers, opioid use disorder
  4. Hyperbaric bupivacaine+Sufentanil Approved · Lxo Ireland Designated · Anesthesia; Functional
  5. Sufentanil Approved · First People's Hospital · Arteriovenous Malformation
  6. Sugammadex hameln /ml oplossing voor injectie for General anesthesia Approved · Disc Medicine · General anesthesia
  7. intravenous sufentanil Approved · Chinese Academy of · Analgesia, Patient-Controlled
  8. 20250527IIT0060 Unknown · Chinese Academy of · Dexmedetomidine Induced Sedation

Related & competitor drugs

  1. aripiprazole Nervous system (N05)
  2. brexpiprazole Nervous system (N05)
  3. brivaracetam Nervous system (N03)
  4. bupivacaine Nervous system (N01)
  5. buprenorphine Nervous system (N07)
  6. caffeine citrate Nervous system (N06)

Frequently asked questions

What is sufentanil?

sufentanil (DZUVEO) is a mu opioid receptor agonist.

What is the brand name for sufentanil?

DZUVEO is a marketed brand name for sufentanil. Check FDA Drugs@FDA for the current US label holder and prescribing information.